Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.

× No keyword cloud information.

12 in total

Review 1. Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors: Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal: Obes Surg Date: 2012-01 Impact factor: 4.129

2. Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis.

Authors: Payal Agarwal; Pulkit Khatri; Blasé Billack; Woon-Kai Low; Jun Shao
Journal: Pharm Res Date: 2014-06-14 Impact factor: 4.200

3. Effect of gastric bypass combined with ileal transportation on type 2 diabetes mellitus.

Authors: Zhaoxia Gao; Bin Wang; Xiaojun Gong; Chun Yao; Defa Ren; Liwei Shao; Yan Pang; Jinxiu Liu
Journal: Exp Ther Med Date: 2018-03-06 Impact factor: 2.447

4. The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus.

Authors: Mi-Hyun Kim; Moon-Kyu Lee
Journal: Korean Diabetes J Date: 2010-02-28

Review 5. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.

Authors: S Calanna; M Christensen; J J Holst; B Laferrère; L L Gluud; T Vilsbøll; F K Knop
Journal: Diabetologia Date: 2013-02-03 Impact factor: 10.122

6. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

Authors: A L DePaula; A L V Macedo; N Rassi; C A Machado; V Schraibman; L Q Silva; A Halpern
Journal: Surg Endosc Date: 2008-03 Impact factor: 4.584

7. Hypoglycemia associated with off-label sitagliptin use.

Authors: Heather P Whitley; Kristi Kelley
Journal: Int Med Case Rep J Date: 2008-11-11

8. Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid.

Authors: Maria F Fernandes; Michelle V Tomczewski; Robin E Duncan
Journal: Int J Mol Sci Date: 2022-04-09 Impact factor: 6.208

9. The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial.

Authors: Signe Foghsgaard; Louise Vedtofte; Elisabeth R Mathiesen; Jens A Svare; Lise L Gluud; Jens J Holst; Peter Damm; Filip K Knop; Tina Vilsbøll
Journal: BMJ Open Date: 2013-10-30 Impact factor: 2.692

10. Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.

Authors: Ralph A DeFronzo; Curtis Triplitt; Yongming Qu; Michelle S Lewis; David Maggs; Leonard C Glass
Journal: Diabetes Care Date: 2010-01-27 Impact factor: 19.112